NDC Package 0023-9652-03 Durysta

Bimatoprost Implant Intracameral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0023-9652-03
Package Description:
1 IMPLANT in 1 POUCH
Product Code:
Proprietary Name:
Durysta
Non-Proprietary Name:
Bimatoprost
Substance Name:
Bimatoprost
Usage Information:
Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (e.g., ocular hypertension). Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure.
11-Digit NDC Billing Format:
00023965203
NDC to RxNorm Crosswalk:
  • RxCUI: 2286602 - bimatoprost 10 MCG Intracameral Implant
  • RxCUI: 2286602 - bimatoprost 0.01 MG Drug Implant
  • RxCUI: 2286602 - bimatoprost 10 MCG Drug Implant
  • RxCUI: 2286607 - DURYSTA 10 MCG Intracameral Implant
  • RxCUI: 2286607 - bimatoprost 0.01 MG Drug Implant [Durysta]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Allergan, Inc.
    Dosage Form:
    Implant - A material containing drug intended to be inserted securely of deeply in a living site for growth, slow release, or formation of an organic union.
    Active Ingredient(s):
    Sample Package:
    Yes
    FDA Application Number:
    NDA211911
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    03-04-2020
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0023-9652-011 IMPLANT in 1 POUCH

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0023-9652-03?

    The NDC Packaged Code 0023-9652-03 is assigned to a package of 1 implant in 1 pouch of Durysta, a human prescription drug labeled by Allergan, Inc.. The product's dosage form is implant and is administered via intracameral form.

    Is NDC 0023-9652 included in the NDC Directory?

    Yes, Durysta with product code 0023-9652 is active and included in the NDC Directory. The product was first marketed by Allergan, Inc. on March 04, 2020 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0023-9652-03?

    The 11-digit format is 00023965203. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20023-9652-035-4-200023-9652-03